home / stock / tak / tak news


TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 11/07/23

Stock Information

Company Name: Takeda Pharmaceutical Company Limited American Depositary Shares
Stock Symbol: TAK
Market: NYSE
Website: takeda.com

Menu

TAK TAK Quote TAK Short TAK News TAK Articles TAK Message Board
Get TAK Alerts

News, Short Squeeze, Breakout and More Instantly...

TAK - Asia-Pacific stocks lower amid weak China trade data, dovish RBA rate hike

2023-11-07 03:10:18 ET Japan ( NKY:IND ) -1.34% . Japan data - September Household Spending -2.8% y/y (vs. expected -2.7%). Japan data - September Labor Cash Earnings +1.2% y/y (expected +1.0%). China ( SHCOMP ) -0.04%. China October exports -6.4% ...

TAK - Portfolio Update: Next Trades

2023-11-05 12:17:29 ET Summary The UST yield curve has steepened and this could provide an opportunity to buy US banking stocks on weakness in a no-recession scenario. Japan and Eurozone exporters can benefit from a global downturn due to easier central bank policies depreciating ...

TAK - Asia-Pacific stocks higher tracking global markets ahead of the monthly jobs report

2023-11-03 02:22:51 ET Japan ( NKY:IND ) markets closed . China ( SHCOMP ) +0.72%. China services PMI edges slightly higher to 50.4, composite fell to 50 in October Hong Kong ( HSI ) +2.47% . The S&P Global Hong Kong SAR PMI dropp...

TAK - Asia-Pacific stocks mostly rise after Fed stays on hold; eyes on ECB decision

2023-11-02 02:59:35 ET Japan ( NKY:IND ) +1.10% . Japan 10 year JGB auction average yield of 0.910% China ( SHCOMP ) -0.23% . China 10 Year Government Bond Yield decreased to a 5-week low of 2.686%. Hong Kong ( HSI ) +0.80% . India...

TAK - Analyzing The Acquisition Potential Of ImmunoGen

2023-10-31 15:25:10 ET Summary ImmunoGen, Inc.'s marketing authorization application for ELAHERE, a cancer therapy, has been accepted by the EMA. Rumors suggest that large European pharma companies, including GSK, Sanofi, or Merck, may be interested in ImmunoGen. ImmunoGen has...

TAK - Amicus Therapeutics: The Right Play Now

2023-10-31 12:24:58 ET Summary Amicus Therapeutics, Inc. is a commercial-stage biotech company focused on developing therapies for rare diseases. The company recently received FDA approval for its combination therapy Pombiliti + Opfolda for Pompe disease. Amicus Therapeutics i...

TAK - Asia-Pacific stocks mixed on weak China data; BOJ policy tweak

2023-10-31 03:13:29 ET Japan ( NKY:IND ) +0.53% . Bank of Japan tweaks yield curve control policy, holds interest rates Japan September factory output, retail sales rise; jobless rate falls to 2.6% . Japan's JGB 10 year yield hits 0.955%, highest since May ...

TAK - Asia-Pacific stocks mixed ahead of key central bank meetings, tensions in the Middle East

2023-10-30 02:47:35 ET Japan ( NKY:IND ) -0.97% . Japan’s 10-year government bond yield rose toward 0.9%, hitting fresh 10-year highs amid growing speculations that the Bank of Japan would hike its existing yield cap at this week’s policy meeting. China&#x...

TAK - Pharma, PBMs spar over rising drug costs amid public scrutiny

2023-10-29 12:00:27 ET More on PBMs Cigna PBM unit Express Scripts sued for overcharging pharmacies FTC investigating purchasing organizations that work on behalf of PBMs Eli Lilly, Novo, Sanofi and leading PBMs accused in California over insulin prices CVS H...

TAK - Ironwood Pharmaceuticals: The Right Play Now

2023-10-27 16:13:47 ET Summary Ironwood Pharmaceuticals, Inc. is a Boston-based drug company focused on developing treatments for gastrointestinal disorders. The company's revenue-generating product is Linzess, which is approved for multiple GI indications. Ironwood recently a...

Previous 10 Next 10